SCHEMBL7701177

SCHEMBL7701177

CCOC(=O)C1=Cc2cccc(SC)c2OCC1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.39
TSHR P16473 2/20 0.39
NPSR1 Q6W5P4 2/20 0.39
LMNA P02545 1/20 0.39
CA12 O43570 2/20 0.36
CA9 Q16790 2/20 0.36
CA1 P00915 1/20 0.35
CA2 P00918 1/20 0.35
CA7 P43166 1/20 0.35
CA14 Q9ULX7 1/20 0.35
CYP1A2 P05177 1/20 0.35
PREP P48147 2/20 0.34
CYP4F2 P78329 1/20 0.34
CYP4A11 Q02928 1/20 0.34
KMT2A Q03164 2/20 0.33
MEN1 O00255 1/20 0.33
HPGD P15428 1/20 0.33
NPC1 O15118 1/20 0.33
CLK1 P49759 1/20 0.33
RAB9A P51151 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7702476 0.89 ALDH1A1 (0.35) ALDH1A1TSHRCA12CA9CA1
SCHEMBL7385304 0.85 MAPT (0.39) ALDH1A1TSHRCA12CA9CA1
SCHEMBL7696668 0.84 CA12 (0.48) ALDH1A1TSHRLMNACA12CA9
SCHEMBL7699846 0.84 TSHR (0.46) ALDH1A1TSHRNPSR1LMNACA12
SCHEMBL7385154 0.83 ALDH1A1 (0.43) ALDH1A1TSHRLMNACA12CA9
SCHEMBL7698997 0.83 CYP4F2 (0.41) ALDH1A1TSHRCA12CA9CA1
SCHEMBL7386364 0.83 CA12 (0.37) ALDH1A1TSHRCA12CA9CA1
SCHEMBL7385104 0.83 NOTUM (0.40) ALDH1A1TSHRLMNACA12CA9
SCHEMBL7700639 0.82 ALDH1A1 (0.40) ALDH1A1TSHRNPSR1LMNACA12
SCHEMBL7702968 0.82 TSHR (0.41) ALDH1A1TSHRNPSR1CA12CA9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6346527-B1 1-BENZOXEPIN DERIVATIVES USED IN THE PREVENTION OF SODIUM AND HYDROGEN ION EXCHANGE; CARDIOVASCULAR, KIDNEY AND BRAIN DISORDER TREATMENT; ARTERIOSCLEROSIS FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 2002-02-12 US disclosed
EP-1073650-A1 GUANIDINE DERIVATIVES FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 2001-02-07 EP disclosed
WO-1999055690-A1 GUANIDINE DERIVATIVES FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1999-11-04 WO disclosed